Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Koh, Kyung-Nam | - |
dc.contributor.author | Yoo, Keon Hee | - |
dc.contributor.author | Im, Ho Joon | - |
dc.contributor.author | Sung, Ki Woong | - |
dc.contributor.author | Koo, Hong Hoe | - |
dc.contributor.author | Kim, Hyo Sun | - |
dc.contributor.author | Han, Jung Woo | - |
dc.contributor.author | Yoon, Jong Hyung | - |
dc.contributor.author | Park, Hyeon Jin | - |
dc.contributor.author | Park, Byung-Kiu | - |
dc.contributor.author | Baek, Hee Jo | - |
dc.contributor.author | Kook, Hoon | - |
dc.contributor.author | Lee, Jun Ah | - |
dc.contributor.author | Lee, Jae Min | - |
dc.contributor.author | Lee, Kwang Chul | - |
dc.contributor.author | Kim, Soon Ki | - |
dc.contributor.author | Park, Meerim | - |
dc.contributor.author | Lee, Young-Ho | - |
dc.contributor.author | Lyu, Chuhl Joo | - |
dc.contributor.author | Seo, Jong Jin | - |
dc.date.accessioned | 2021-09-03T21:26:56Z | - |
dc.date.available | 2021-09-03T21:26:56Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-08 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87925 | - |
dc.description.abstract | This retrospective study investigated the clinical characteristics and outcomes of second malignant neoplasms (SMNs) in survivors of childhood cancer from multiple institutions in Korea. A total of 102 patients from 11 institutions who developed SMN after childhood cancer treatment between 1998 and 2011 were retrospectively enrolled. The most common primary malignant neoplasms (PMNs) were central nervous system (CNS) tumors (n = 17), followed by acute lymphoblastic leukemia (n = 16), non-Hodgkin lymphoma (n = 13), and osteosarcoma (n = 12). The most common SMNs were therapy-related myeloid neoplasms (t-MNs; acute myeloid leukemia [AML], 29 cases; myelodysplastic syndrome [MDS], 12 cases), followed by thyroid carcinomas (n = 15) and CNS tumors (n = 10). The median latency period was 4.9 years (range, 0.5-18.5 years). Among 45 patients with solid tumors defined as an SMN, 15 (33%) developed the lesion in a field previously subjected to radiation. The 5-year overall survival (OS) rate of patients with an SMN was 45% with a median follow-up time of 8.6 years. Patients with AML, MDS, and CNS tumors exhibited the poorest outcomes with 5-year OS rates of 18%, 33%, and 32%, respectively, whereas those with second osteosarcoma showed comparable outcomes (64%) to patients with primary counterpart and those with second thyroid carcinoma had a 100% OS rate. Further therapeutic efforts are recommended to improve the survival outcomes in patients with SMNs, especially in cases with t-MNs and CNS tumors. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | ACUTE LYMPHOBLASTIC-LEUKEMIA | - |
dc.subject | MYELOID-LEUKEMIA | - |
dc.subject | SURVIVORS | - |
dc.subject | ADOLESCENCE | - |
dc.subject | EXPERIENCE | - |
dc.subject | COHORT | - |
dc.subject | REGISTRY | - |
dc.subject | RISKS | - |
dc.title | Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwang Chul | - |
dc.identifier.doi | 10.3346/jkms.2016.31.8.1254 | - |
dc.identifier.scopusid | 2-s2.0-85047290052 | - |
dc.identifier.wosid | 000379157900012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.31, no.8, pp.1254 - 1261 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 31 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1254 | - |
dc.citation.endPage | 1261 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002131409 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ACUTE LYMPHOBLASTIC-LEUKEMIA | - |
dc.subject.keywordPlus | MYELOID-LEUKEMIA | - |
dc.subject.keywordPlus | SURVIVORS | - |
dc.subject.keywordPlus | ADOLESCENCE | - |
dc.subject.keywordPlus | EXPERIENCE | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordPlus | REGISTRY | - |
dc.subject.keywordPlus | RISKS | - |
dc.subject.keywordAuthor | Childhood | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Survivors | - |
dc.subject.keywordAuthor | Second Neoplasm | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.